About
RespiDx is a social impact venture that has developed the Multimometer, a device designed to enable simple diagnosis of pneumonia and febrile disease in the field by untrained community health workers. The automatic diagnosis of pneumonia is based on World Health Organization diagnostic criteria. RespiDxs efforts are currently focused on optimizing the companys pneumonia diagnosis device for mass manufacturing and market entry. Clinical studies of the Multimometer have been performed in the Democratic Republic of the Congo. RespiDxs activities in diagnosing pneumonia in underdeveloped countries are supported by Grand Challenges Israel, USAid, and Grand Challenges Canada.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary product developed by RespiDx?
- RespiDx developed the Multimometer, a device for diagnosing pneumonia and febrile disease in the field by untrained community health workers.
- When was RespiDx founded?
- RespiDx was founded in March 2015.
- What is the current operational status of RespiDx?
- RespiDx is currently inactive, having ceased operations in May 2019.
- Where has RespiDx conducted clinical studies for its Multimometer device?
- Clinical studies of the Multimometer have been performed in the Democratic Republic of the Congo.
- Which organizations have supported RespiDx's activities in diagnosing pneumonia in underdeveloped countries?
- RespiDx's activities are supported by Grand Challenges Israel, USAid, and Grand Challenges Canada.
- How much total funding has RespiDx raised?
- RespiDx has raised a total of $400,000 USD in grants, including $250,000 in March 2016 from IIA.
- What is the employee count for RespiDx?
- RespiDx has an employee count in the range of 1-10, with an exact count of 6 employees.
- What is the primary sector of RespiDx?
- RespiDx's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Diagnostics Devices.
- Who are the founders of RespiDx?
- The founders of RespiDx include Dr. Keren Fradkin, Amir Elhasid, Prof. Israel Amirav, and Ian Solomon.